SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported fourth-quarter earnings of $14.3 million.
On a per-share basis, the South San Francisco, California-based company said it had net income of 80 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 55 cents per share.
The drug developer posted revenue of $57.6 million in the period.
For the year, the company reported profit of $17.5 million, or 99 cents per share. Revenue was reported as $179.3 million.
Rigel expects full-year revenue in the range of $200 million to $210 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
